BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7678309)

  • 1. Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r.
    Ohnuma H; Machida A; Okamoto H; Tsuda F; Sakamoto M; Tanaka T; Miyakawa Y; Mayumi M
    J Virol; 1993 Feb; 67(2):927-32. PubMed ID: 7678309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen.
    Ohnuma H; Takai E; Machida A; Tsuda F; Okamoto H; Tanaka T; Naito M; Munekata E; Miki K; Miyakawa Y
    J Immunol; 1990 Oct; 145(7):2265-71. PubMed ID: 1697880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen with an excess or deficiency in subtypic determinants in sera from asymptomatic carriers in Japan.
    Tachibana K; Tanaka T; Usuda S; Okamoto H; Tsuda F; Akahane Y; Miyakawa Y; Mayumi M
    Viral Immunol; 1989; 2(1):25-9. PubMed ID: 2472809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen particles with all four subtypic determinants: point mutations of hepatitis B virus DNA inducing phenotypic changes or double infection with viruses of different subtypes.
    Yamanaka T; Akahane Y; Suzuki H; Okamoto H; Tsuda F; Miyakawa Y; Mayumi M
    Mol Immunol; 1990 May; 27(5):443-9. PubMed ID: 1694959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A solid-phase enzyme immunoassay for the common and subtypic determinants of hepatitis B surface antigen with monoclonal antibodies.
    Usuda S; Tsuda F; Gotanda T; Tachibana K; Nomura M; Okamoto H; Imai M; Nakamura T; Miyakawa Y; Mayumi M
    J Immunol Methods; 1986 Mar; 87(2):203-10. PubMed ID: 2419452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and subtypic determinants of hepatitis B surface antigen particles: susceptibility to reduction and/or alkylation evaluated with monoclonal antibodies.
    Luengrojanakul P; Ohnuma H; Tachibana K; Usuda S; Okamoto H; Tanaka T; Tsuda F; Machida A; Mayumi M
    Jpn J Exp Med; 1990 Oct; 60(5):253-61. PubMed ID: 1706785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen particles of subtypes adw and adr, and compound subtype (adwr) in symptom-free carriers in Japan.
    Kanagawa H; Takai E; Tsuda F; Machida A; Kojima M; Ishijima A; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1992 Aug; 37(4):288-93. PubMed ID: 1383415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen.
    Okamoto H; Omi S; Wang Y; Itoh Y; Tsuda F; Tanaka T; Akahane Y; Miyakawa Y; Mayumi M
    Mol Immunol; 1989 Feb; 26(2):197-205. PubMed ID: 2465492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product.
    Usuda S; Okamoto H; Tanaka T; Kidd-Ljunggren K; Holland PV; Miyakawa Y; Mayumi M
    J Virol Methods; 2000 Jun; 87(1-2):81-9. PubMed ID: 10856755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.
    McMahon G; Ehrlich PH; Moustafa ZA; McCarthy LA; Dottavio D; Tolpin MD; Nadler PI; Ostberg L
    Hepatology; 1992 May; 15(5):757-66. PubMed ID: 1568715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.
    Okamoto H; Imai M; Tsuda F; Tanaka T; Miyakawa Y; Mayumi M
    J Virol; 1987 Oct; 61(10):3030-4. PubMed ID: 3041023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.
    Yamamoto K; Horikita M; Tsuda F; Itoh K; Akahane Y; Yotsumoto S; Okamoto H; Miyakawa Y; Mayumi M
    J Virol; 1994 Apr; 68(4):2671-6. PubMed ID: 8139044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
    Karthigesu VD; Allison LM; Ferguson M; Howard CR
    J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA.
    Swenson PD; Van Geyt C; Alexander ER; Hagan H; Freitag-Koontz JM; Wilson S; Norder H; Magnius LO; Stuyver L
    J Med Virol; 2001 Jul; 64(3):305-11. PubMed ID: 11424119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody to the "y" determinant of HBsAg in a chimpanzee carrier of HBsAg subtype "adw".
    Tabor E; Gerety RJ; Smallwood LA; Barker LF
    J Immunol; 1976 Nov; 117(5 Pt.2):2038-40. PubMed ID: 62804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.
    Margeridon S; Lachaux A; Trepo C; Zoulim F; Kay A
    J Gen Virol; 2005 Jun; 86(Pt 6):1687-1693. PubMed ID: 15914846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.